Crossmark Global Holdings, Inc. Charles River Laboratories International, Inc. Transaction History
Crossmark Global Holdings, Inc.
- $5.23 Billion
- Q2 2024
A detailed history of Crossmark Global Holdings, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 5,968 shares of CRL stock, worth $1.16 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,968
Previous 6,025
0.95%
Holding current value
$1.16 Million
Previous $1.63 Million
24.49%
% of portfolio
0.02%
Previous 0.03%
Shares
28 transactions
Others Institutions Holding CRL
# of Institutions
732Shares Held
51.8MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.18 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$987 Million0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$405 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$370 Million0.99% of portfolio
-
Clearbridge Investments, LLC New York, NY1.37MShares$266 Million0.24% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.87B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...